Transgenic mammal secreting B-domain deleted human FVII in...

Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S004000, C800S015000, C800S016000, C800S017000, C800S018000, C800S021000

Reexamination Certificate

active

07667089

ABSTRACT:
Hemophilia A is one of the major inherited bleeding disorders caused by a deficiency or abnormality in coagulation factor VIII (FVIII). Hemophiliacs have been treated with whole plasma or purified FVIII concentrates. The risk of transmitting blood-borne viruses and the cost of highly purified FVIII are the major factors that restrict prophylaxis in hemophilia therapy. One of the challenges created by the biotechnology revolution is the development of methods for the economical production of highly purified proteins in large scales. The present invention provides improved mammary expression cassettes useful for the expression of genes at high levels in the milk of transgenic animals. In particular, the present invention provides recombinant signal peptide sequences derived from a-lactalbumin and aS1-casein milk genes suitable for leading protein secretion in the mammary gland. These gene cassettes are capable of delivering different transgenic constructs which result in the production of full-length or B domain-deleted therapeutic levels of biologically active human FVIII in the transgenic animals in vivo. Within the scope of the invention are also method for producing the transgenic non-human mammal, such as mouse, rat, rabbit, goat, sheep, pig and bovine species, capable of expressing human FVIII, and methods of making milk and methods of identifying protein from the transgenic milk.

REFERENCES:
patent: 5633076 (1997-05-01), DeBoer et al.
patent: 6255554 (2001-07-01), Lubon et al.
patent: WO 9800541 (1998-01-01), None
Niemann et al, Animal Reproduction Science, 79:291-317, 2003.
Houdebine et al, Transgenic Research, 9:305-320, 2000.
Chen et al, Transgenic Research, 11:257-268, 2002.
Niemann et al, Transgenic Research, 8:237-247.
Paleyanda et al, Nature Biotechnology, 15:971-975, 1997.
Hiripi et al, DNA and Cell Biology, 22:41-45, 2003.
Soukharev et al, Blood Cells, Molecules and Diseases, 28:234-248, 2002.
Toole (PNAS, Aug. 1986, vol. 83, p. 5939-5942).
Pittman (Blood, 1993, vol. 81, p. 2925-2935).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transgenic mammal secreting B-domain deleted human FVII in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic mammal secreting B-domain deleted human FVII in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic mammal secreting B-domain deleted human FVII in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4230857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.